My HPRA: Register

VAXZEVRIA/COVID-19 Vaccine AstraZeneca - Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC as approved by the HPRA

Notice type: 3rd Party Publications

Date: 14/04/2021

Problem Or Issue:

Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC regarding VAXZEVRIA/COVID-19 Vaccine AstraZeneca: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia

Important Safety Information - VAXZEVRIA/COVID-19 Vaccine AstraZeneca

« Back